We look at the drug firms – led by Pfizer and Moderna – that are set to profit most in an unprecedented global vaccination drive
Drugmakers led by US firms Pfizer and Moderna stand to make tens of billions of dollars from their Covid-19 vaccines this year and next, given G7 governments’ pledge to vaccinate the entire world by the end of 2022, but sales are likely to drop sharply thereafter, according to analysts.
Acclaimed for allowing a return to more normal life, Covid vaccines will also substantially benefit some pharmaceutical companies. The global market for the vaccines is worth $70bn (£50bn) this year, says Karen Andersen of Morningstar.
This is the biggest global vaccination campaign in history, with more than 2.5bn doses administered in 180 countries
